JACC Basic to Translational Science · 2022 · 21 citations · 39 references
MedicineBioengineeringSurgeryBiocompatibilityBiomaterialsVascular SurgeryCardiovascular BiomaterialsCoronary Artery SurgeryGraft SurvivalImplantable BiomaterialsBypass Graft MaterialsBypass Graft Patency AssessmentClinical Utility AnalysisClinical Utility AssessmentFailure ModesGraft EngineeringSaphenous Vein Grafting
Many attempts have been made to inhibit or counteract saphenous vein graft (SVG) failure modes; however, only external support for SVGs has gained momentum in clinical utility. This study revealed the feasibility of implantation, and showed good patency out to 12 months of the novel biorestorative graft, in a challenging ovine coronary artery bypass graft model. This finding could trigger the first-in-man trial of using the novel material instead of SVG. We believe that, eventually, this novel biorestorative bypass graft can be one of the options for coronary artery bypass graft patients who have difficulty harvesting SVG.
39
C. Michael Gibson, Christopher P. Cannon, William Daley et al. · Circulation · 1996 · 1.9K citations
Gerald M. FitzGibbon, Henryk Kafka, Alan J. Leach et al. · Journal of the American College of Cardiology · 1996 · 1.4K citations
Medicine, Cardiology, Surgery +9